Clinical Trials
In order for a new treatment to move from a concept in the laboratory of an individual researcher to availability for us to use in the office routinely, a number of steps are required. In many cases, the important final step is evaluation of the new treatment in a large clinical trial. In a clinical trial, the new treatment is compared to one or more other existing treatments, when there is one available, or to no treatment. The outcome of interest in the clinical trial typically is a measure of visual function, such as visual acuity or visual field, but may be a measure of patient satisfaction or vision-related quality of life or benefit relative to cost. Of course, safety of the patient is our primary concern.
Georgia Retina, P.C. has a long history of commitment to and participation in clinical trials in order to provide our patients access to new, state-of-the-art preventative, or therapeutic, treatments. At Georgia Retina, our goal is to provide patients the opportunity to participate in clinical trials of new treatments for retinal diseases. We partner with the National Eye Institute, some of the nation's top pharmaceutical companies, and other clinical practices to explore the causes and cures for many retinal conditions.
We take special care to ensure that our study patients experience the best medical care possible. It is easy for patients to participate successfully in our studies and make informed decisions about their condition. Feel free to contact us to determine if you may be eligible for a study. Eligibility is determined through a screening process that varies for each clinical trial. If you are determined to be ineligible for a study, the doctors and staff of Georgia Retina, P.C. will continue to care for your eyes and provide you with the best care available.
Trials Actively Enrolling Patients at Georgia Retina
AREDS2 ForeseeHome
Trials No Longer Enrolling Patients
AREDS2
DRCR.net Protocol N
Novartis CSPP100A2244
RIDE FVF4168g
RISE FVF4170g
Recently Completed Trials
AART C-02-60
ALLERGAN 206207-012
HORIZON FVF3426g
MARINA FVF2598g
PDEX
SAILOR FVF3689g
SCORE
Georgia Retina, P.C. continues its dedication to the advancement of ophthalmic science and patient care through the active participation in well-designed, randomized, controlled clinical trials. By doing so, Georgia Retina can help to bring new and innovative therapies for many blinding conditions into clinical practice and to our patients.
Georgia Retina's Study Coordinator — Leslie Marcus, B.S., CCRC
Leslie has more than 7 years of clinical research experience. In addition to experience conducting ophthalmology studies she has also coordinated clinical trials for conditions such as Diabetes, Diabetic Neuropathy, Chronic Pain, Hypercholesterolemia, Hyperlipidemia, Insomnia, Obesity, Osteoarthritis, and Postherpetic Neuralgia.
She received a Bachelor's of Science degree with a major in Nutrition and Food Science from Georgia Southern University in 2000. Leslie became a Certified Clinical Research Coordinator through the Association of Clinical Research Professionals in 2004.
Leslie serves as a vital link in communicating between the practice and the research sponsor team. She manages the research personnel and handles the administrative responsibilities of clinical trials from the developmental phases to the completion of the studies.
When asked what she likes most about conducting clinical trials Leslie said, "I am passionate about clinical research because it helps to provide our patients with the possibility of receiving treatments that may not have been available to them. Hopefully, the trials that we are involved in will help to make a positive difference in the lives of our patients."
If you wish to participate in clinical trials at Georgia Retina, P.C., please contact Leslie at (404) 299-5209.